The mechanism has not been fully elucidated but likely involves the vascular nature of NETs when compared to other tumor types, vasoactive peptides secreted by NETs, and potentially the concurrent use of somatostatin analogs which can also be associated with hypertension.18 In this trial, almost half of the patients had hypertension prior to enrollment. The gene discussed is SST; the disease is hypertensive disorder.